Iofetamine (123I)
A radiopharmaceutical used in brain imaging
Iofetamine (123I)[edit]

Iofetamine (123I), also known as N-isopropyl-p-iodoamphetamine (IMP), is a radiopharmaceutical agent used primarily in nuclear medicine for brain imaging. It is a derivative of amphetamine and is labeled with the radioactive isotope iodine-123.
Chemical properties[edit]
Iofetamine is a lipophilic compound, which allows it to cross the blood-brain barrier efficiently. The presence of the iodine-123 isotope enables it to be detected using single-photon emission computed tomography (SPECT), a type of nuclear imaging technique.
Mechanism of action[edit]
Once administered, iofetamine (123I) is taken up by the brain tissue, where it is distributed in proportion to the regional cerebral blood flow. This property makes it useful for assessing cerebral perfusion and identifying areas of altered blood flow, which can be indicative of various neurological disorders.
Clinical applications[edit]
Iofetamine (123I) is used in the evaluation of several neurological conditions, including:
- Stroke: To assess the extent of brain tissue affected by ischemia.
- Epilepsy: To localize epileptogenic foci by identifying regions of altered perfusion.
- Dementia: To evaluate patterns of cerebral blood flow that may be characteristic of different types of dementia.
Administration and imaging[edit]
The compound is typically administered intravenously. After administration, imaging is performed using a SPECT camera, which detects the gamma rays emitted by the decay of iodine-123. The resulting images provide information about the distribution of blood flow in the brain.
Safety and side effects[edit]
Iofetamine (123I) is generally well-tolerated. However, as with any radiopharmaceutical, there is a small risk of radiation exposure. The use of iodine-123, which has a relatively short half-life, helps to minimize this risk. Common side effects are rare but may include mild allergic reactions.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian